Cargando…
Bowman‒Birk Inhibitor Suppresses Herpes Simplex Virus Type 2 Infection of Human Cervical Epithelial Cells
The Bowman‒Birk inhibitor (BBI), a protease inhibitor derived from soybeans, has been extensively studied in anti-tumor and anti-inflammation research. We recently reported that BBI has an anti-HIV-1 property in primary human macrophages. Because HSV-2 infection plays a role in facilitating HIV-1 se...
Autores principales: | Liu, Yu, Xu, Xi-Qiu, Zhang, Biao, Gu, Jun, Meng, Feng-Zhen, Liu, Hang, Zhou, Li, Wang, Xu, Hou, Wei, Ho, Wen-Zhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213026/ https://www.ncbi.nlm.nih.gov/pubmed/30322047 http://dx.doi.org/10.3390/v10100557 |
Ejemplares similares
-
Soybean-derived Bowman-Birk inhibitor inhibits neurotoxicity of LPS-activated macrophages
por: Li, Jieliang, et al.
Publicado: (2011) -
Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages
por: Ma, Tong-Cui, et al.
Publicado: (2016) -
Corrigendum: Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages
por: Ma, Tong-Cui, et al.
Publicado: (2016) -
Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor
por: Miao, Yuxi, et al.
Publicado: (2019) -
A Bowman-Birk type chymotrypsin inhibitor peptide from the amphibian, Hylarana erythraea
por: Zhang, Luyao, et al.
Publicado: (2018)